ユタにおける自己免疫疾患の臨床試験
ユタ内の拠点で、自己免疫疾患に関する7件の研究が参加者を募集しています。
ユタ内の都市
公式研究テキスト（英語）
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Primary Children's Hospital/University of Utah - Accepting Juvenile Patients, Salt Lake City
被験者募集中第2/3相
6歳〜75歳 · 全性別 · 2026/09/17更新 · NCT06154252A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- LDS Hospital - lntermountain Health, Salt Lake City
被験者募集中第1相
18歳〜74歳 · 全性別 · 2026/09/10更新 · NCT07085104A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06572384A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- University of Utah, Salt Lake City
被験者募集中第3相
12歳以上 · 全性別 · 2026/08/06更新 · NCT06056297KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Intermountain Medical Center, Murray
被験者募集中第2/3相
18歳〜75歳 · 全性別 · 2026/07/29更新 · NCT06193889A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Utah, Salt Lake City
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems
- Primary Children's Hospital/University of Utah, Salt Lake City
被験者募集中
0歳〜60歳 · 全性別 · 2024/11/25更新 · NCT03953768ClinicalTrials.govより、2026/10/04時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。